z-logo
open-access-imgOpen Access
In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2)
Author(s) -
J. L. Muñioz-Bellido,
S. Muñioz-Bellido,
J. A. García-Rodrfguez
Publication year - 1996
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/37.5.1005
Subject(s) - ciprofloxacin , microbiology and biotechnology , tetracycline , clindamycin , cefotaxime , antibacterial agent , teicoplanin , sertraline , trimethoprim , pharmacology , medicine , antibiotics , vancomycin , biology , bacteria , staphylococcus aureus , antidepressant , genetics , hippocampus
We tested the in-vitro activity of amoxycillin, amoxycillin/clavulanic acid, cefotaxime, gentamicin, trimethoprim-sulphamethoxazole, tetracycline, norfloxacin, ciprofloxacin, vancomycin, teicoplanin, clindamycin and five psychiatric drugs (chlorpromazine, sertraline, fluoxetine, paroxetine and risperidone) against 32 strains of Corynebacterium urealyticum. Resistance rates exceeded 90% for all antibiotics except glycopeptides, quinolones and tetracycline. Sertraline was the most active psychiatric drug. We tested the influence of sertraline on the activity of amoxycillin, amoxycillin/clavulanic acid, cefotaxime, gentamicin, trimethoprim-sulphamethoxazole, tetracycline and ciprofloxacin. We did not observe antagonism in any case. Sertraline enhanced the activity of ciprofloxacin and tetracycline against all strains (MIC decrease: 4-64-fold for ciprofloxacin, 2-32-fold for tetracycline).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom